Inventor

DUMBLE MELISSA

US7 patents

⚠️ This page may combine multiple inventors who share the name “DUMBLE MELISSA”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.

DUMBLE MELISSA

3 patents

US8703781B2Apr 22, 2014

Pharmaceutical combination of MEK inhibitor and B-RAF inhibitors

DUMBLE MELISSA14 citations79

US8835450B2Sep 16, 2014

Combination of inhibitor of B-Raf and an inhibitor of Akt in the treatment of cancer

DUMBLE MELISSA0 citations45

US8796298B2Aug 5, 2014

Combination of a B-Raf inhibitor: N-{3-[5-(2-Amino-4-pyrimidinyl)-2-(1,1- dimethylethyl)-1,3-thiazol-4-yl]-2-fluorophenyl}-2,6-difluorobenzenesulfonamide and the Akt inhibitor: N-{ (1S)-2-amino-1-[(3- fluorophenyl)methyl]ethyl}-5-chIoro-4-(4-chIoro- 1 -methyl- 1 H-pyrazol-5-yl)-2-10 thiophenecarboxamide useful in the treatment of cancer

DUMBLE MELISSA1 citations45

PMV PHARMACEUTICALS INC

2 patents

US11938124B2Mar 26, 2024

Combination therapy for treatment of cancer

PMV PHARMACEUTICALS INC2 citations66

US12419880B2Sep 23, 2025

Companion diagnostic tool for mutant p53 reactivating compounds

PMV PHARMACEUTICALS INC0 citations48

GLAXOSMITHKLINE LLC

1 patent

US8952018B2Feb 10, 2015

Pharmaceutical combination of MEK inhibitor and B-Raf inhibitors

GLAXOSMITHKLINE LLC13 citations81

NOVARTIS AG

1 patent

US9402846B2Aug 2, 2016

Combination of inhibitor of B-Raf and inhibitor of AKT in the treatment of cancer

NOVARTIS AG0 citations47